Up-front neck dissection followed by chemoradiotherapy for T1-T3 hypopharyngeal cancer with advanced nodal involvement

Head Neck. 2021 Dec;43(12):3810-3819. doi: 10.1002/hed.26881. Epub 2021 Sep 22.

Abstract

Background: The advantage of up-front neck dissection (UFND) followed by chemoradiotherapy (CRT) for hypopharyngeal cancer (HPC) with advanced neck involvement remains controversial. We aimed to determine the indications.

Methods: The data of 41 and 14 patients with stage IVA/B (T1-T3 and ≥N2a) HPC who underwent UFND followed by CRT and received CRT, respectively, were retrospectively analyzed and compared.

Results: The 5-year overall survival (OS) and disease-specific survival rates for the UFND and CRT groups were 61% and 52% (p = 0.1019), and 89% and 74% (p = 0.2333), respectively. Moreover, patients aged ≥70 years or those with a pulmonary disease history had a significantly poorer prognosis due to aspiration pneumonia in the UFND group. The 5-year regional control (RC) for the UFND and CRT groups were 92% and 57%, respectively (p = 0.0001).

Conclusions: UFND followed by CRT was feasible with satisfactory RC. To further improve OS, aspiration pneumonia prevention is essential.

Keywords: chemoradiotherapy; dysphagia; hypopharyngeal cancer; neck dissection; nodal involvement.

MeSH terms

  • Chemoradiotherapy
  • Head and Neck Neoplasms*
  • Humans
  • Hypopharyngeal Neoplasms* / drug therapy
  • Neck Dissection
  • Retrospective Studies
  • Squamous Cell Carcinoma of Head and Neck